GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Doseology Sciences Inc (OTCPK:DOSEF) » Definitions » Net Interest Income

DOSEF (Doseology Sciences) Net Interest Income : $0.02 Mil (TTM As of Sep. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Doseology Sciences Net Interest Income?

Net interest income is the total interest income minus total interest expense. It represents the difference between interest and dividends earned on interestbearing assets and interest paid to depositors and other creditors. Doseology Sciences's net interest income for the three months ended in Sep. 2024 was $0.01 Mil. Its net interest income for the trailing twelve months (TTM) ended in Sep. 2024 was $0.02 Mil.


Doseology Sciences Net Interest Income Historical Data

The historical data trend for Doseology Sciences's Net Interest Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Doseology Sciences Net Interest Income Chart

Doseology Sciences Annual Data
Trend Jun20 Jun21 Jun22 Jun23 Jun24
Net Interest Income
- -0.05 -0.05 0.02 0.02

Doseology Sciences Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Net Interest Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.01 0.01 0.01 0.01

Doseology Sciences Net Interest Income Calculation

Net interest income is the total interest income minus total interest expense. It represents the difference between interest and dividends earned on interestbearing assets and interest paid to depositors and other creditors.

Net Interest Income for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.02 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Doseology Sciences Net Interest Income Related Terms

Thank you for viewing the detailed overview of Doseology Sciences's Net Interest Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Doseology Sciences Business Description

Traded in Other Exchanges
Address
9-3151 Lakeshore Road, Suite 305, Kelowna, BC, CAN, V1W 3S9
Doseology Sciences Inc is a diversified life sciences company, on a mission to reimagine mental health therapies through innovation, technology and sustainability. With a focus on the psychedelic and non-psychedelic compounds, also sale of its branded functional mushroom products. Doseology offers cutting-edge therapeutic products and services, with the focus of making a meaningful impact on the mental health pandemic and improving overall health. Geographically earns it revenue from Canada.

Doseology Sciences Headlines

From GuruFocus

Doseology Opens to American Investors

By PRNewswire PRNewswire 07-11-2022

Doseology Provides Corporate Update

By PRNewswire PRNewswire 01-23-2023

Doseology Opens to American Investors

By PRNewswire PRNewswire 07-01-2022

Doseology Welcomes New CFO

By PRNewswire PRNewswire 03-03-2023

Doseology Uplists to OTCQB Market in USA

By PRNewswire PRNewswire 07-06-2022

Doseology Announces New Director and Corporate Secretary

By PRNewswire PRNewswire 05-05-2023

Doseology Opens to American Investors

By PRNewswire PRNewswire 06-01-2022

Doseology Opens to American Investors

By PRNewswire PRNewswire 06-11-2022

Doseology Opens to American Investors

By PRNewswire PRNewswire 06-21-2022